Literature DB >> 27924639

Similar developmental fluctuations of hepato-renal xanthine oxidoreductase gene expression and xanthine oxidase activity in layer and broiler chicken embryos.

D Naseri1, K Asasi1, I Karimi2,3.   

Abstract

1. Xanthine oxidase (XO) has many physiological functions associated with the synthesis of both antioxidant (uric acid: UA) and numerous oxidants (e.g. H2O2), which makes it an important regulator of the cellular redox potential involving organogenesis. The ontogenetic study of hepatic and renal XO makes a better understanding of the putative role of this enzyme in the development of these tissues. 2. Developmental changes of gene expression of xanthine oxidoreductase (XOR), XO activity and UA content of liver and kidney tissues in both broiler and layer chicken embryos were examined during incubation d 14-21. 3. In both strains, hepatic XOR gene expression peaked on d 21 while renal XOR gene expression did not change. 4. The XO activity was higher in kidney than liver in both strains. Hepatic XO activity of both strains peaked on d 18 and thereafter was decreased on d 21. Renal XO activity peaked on d 18 and from then on did not show any significant changes until d 21 in both strains. 5. The UA content was higher in kidney vs. liver in both strains. The hepatic and renal UA values of the both strains increased significantly from d 14 to d 21. 6. The present results showed dissimilar behaviour of XOR gene expression, XO activity and UA content of liver and kidney tissues in both broiler and layer chicken embryos.

Entities:  

Keywords:  Enzymes; gene expression; incubation

Mesh:

Substances:

Year:  2017        PMID: 27924639     DOI: 10.1080/00071668.2016.1268250

Source DB:  PubMed          Journal:  Br Poult Sci        ISSN: 0007-1668            Impact factor:   2.095


  1 in total

1.  An effort toward molecular neuroeconomics of food deprivation induced food hoarding in mice: focus on xanthine oxidoreductase gene expression and xanthine oxidase activity.

Authors:  Isaac Karimi; Shima Motamedi; Lora A Becker
Journal:  Metab Brain Dis       Date:  2017-12-19       Impact factor: 3.584

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.